Variant report
Variant | nsv1018676 |
---|---|
Chromosome Location | chr6:64867241-64904764 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:64898967..64901155-chr6:64903465..64905780,2 | K562 | blood: | |
2 | chr20:46132660..46133356-chr6:64886601..64887388,2 | MCF-7 | breast: | |
3 | chr6:64898967..64901155-chr6:64903465..64905780,2 | K562 | blood: | |
4 | chr6:64825086..64826621-chr6:64878332..64879949,2 | K562 | blood: | |
5 | chr12:81340169..81340734-chr6:64895212..64895734,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs555130132 | chr6:64867258-64867259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs3013160 | chr6:64867268-64867269 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs13190948 | chr6:64867284-64867285 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs145959249 | chr6:64867294-64867295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs546037600 | chr6:64867306-64867307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs564745015 | chr6:64867332-64867333 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs528577235 | chr6:64867348-64867349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs139877895 | chr6:64867383-64867384 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs183083712 | chr6:64867387-64867388 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs529217451 | chr6:64867423-64867424 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs543595014 | chr6:64867426-64867427 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs116411853 | chr6:64867460-64867461 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs533267269 | chr6:64867462-64867463 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs551282339 | chr6:64867470-64867471 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs115444267 | chr6:64867510-64867511 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs561916890 | chr6:64867511-64867512 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs533634961 | chr6:64867543-64867544 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs555467434 | chr6:64867576-64867577 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs567388030 | chr6:64867604-64867605 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs116311730 | chr6:64867638-64867639 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs556202265 | chr6:64867677-64867678 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs373263541 | chr6:64867705-64867706 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs546524758 | chr6:64867740-64867741 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs558050558 | chr6:64867757-64867758 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs149700513 | chr6:64867771-64867772 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs540445093 | chr6:64867783-64867784 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs113309848 | chr6:64867785-64867786 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs186835503 | chr6:64867789-64867790 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs116212426 | chr6:64867794-64867795 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs562589121 | chr6:64867816-64867817 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs148414129 | chr6:64867852-64867853 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs142457555 | chr6:64867853-64867854 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs191310086 | chr6:64867856-64867857 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs147958462 | chr6:64867863-64867864 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs549201129 | chr6:64867867-64867868 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs116002519 | chr6:64867881-64867882 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs537978066 | chr6:64868037-64868038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs112042742 | chr6:64868046-64868047 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs79673864 | chr6:64868047-64868048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs559613574 | chr6:64868049-64868050 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs182173015 | chr6:64868086-64868087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs141706528 | chr6:64868102-64868103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs573481364 | chr6:64868212-64868213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs201174950 | chr6:64868253-64868254 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs61699150 | chr6:64868254-64868255 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs555551258 | chr6:64868288-64868289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs79762183 | chr6:64868302-64868303 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs193059556 | chr6:64868316-64868317 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs562723859 | chr6:64868319-64868320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs533323437 | chr6:64868385-64868386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cancer | 20164919 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:64863200-64869600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
2 | chr6:64865600-64869800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr6:64867400-64867600 | Enhancers | Gastric | stomach |
4 | chr6:64867400-64868000 | Active TSS | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr6:64869600-64871400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
6 | chr6:64869800-64871600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
7 | chr6:64879600-64880600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
8 | chr6:64879800-64880600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
9 | chr6:64880200-64881000 | Enhancers | Fetal Lung | lung |
10 | chr6:64880600-64885200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
11 | chr6:64880600-64885200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
12 | chr6:64885200-64885800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
13 | chr6:64885200-64886000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
14 | chr6:64895800-64896400 | Enhancers | Fetal Lung | lung |
15 | chr6:64896400-64897000 | Flanking Active TSS | Fetal Lung | lung |
16 | chr6:64897000-64897800 | Enhancers | Fetal Lung | lung |